For many people taking psychiatric medications one of the most significant moments in the recovery process is when the thought appears: “maybe it’s time to reduce the dose?” or “can I stop the antidepressant now?”. These are natural questions — pharmacotherapy is usually not an end in itself but a tool to help restore balance.
At the same time the decision to stop medications is one of the more complex therapeutic choices. It is not simply “I feel better, so I stop taking it”, but requires looking at the course of previous treatment, the current life situation, relapse risk and the possible consequences of too-rapid dose reduction of psychiatric medications.
What “stabilisation” before reduction means
One of the most frequently emphasised conditions when reduction is considered is a period of sustained improvement. In practice this means not only a few good days but:
several months of relatively stable mood, anxiety and functioning (at work, in relationships, in daily life),
no clear fluctuations or “micro-relapses” requiring frequent interventions,
a sense that the person already has other coping tools (psychotherapy, lifestyle changes, better regulation of daily rhythm).
From the perspective of a decision to stop medications it is important that the body has time to “learn” to function in a more stable state, not just on a short wave of improvement.
When medication reduction may make sense
Every situation is different and the final decision rests with the doctor, but in practice dose reduction is often considered when:
an adequately long period of stabilisation has passed since the last exacerbation (usually several months, sometimes longer — depending on the diagnosis and number of prior episodes),
other supports have been implemented: psychotherapy, lifestyle modifications, work on sleep, stress and occupational burden,
the person understands their illness mechanism, can recognise early warning signs and knows what to do in such a situation,
the dose taken was previously stable and the treatment was conducted consistently.
When medication reduction may make sense does not automatically mean it must happen now — sometimes choosing the right life moment (e.g. not during a major work project or strong family crisis) is equally important.
When to stop antidepressants — what the doctor typically asks
The question “when to stop antidepressants” often comes up in the clinic. The answer rarely includes a specific date; more often it prompts a series of additional questions that help assess risk. The doctor usually considers among others:
the number of past episodes of depression or anxiety disorders — the more relapses historically, the more cautious the approach to stopping,
the duration of the current episode and time in treatment since improvement,
whether symptoms have fully resolved or some difficulties persist but are less bothersome,
risk factors for relapse: chronic stress, lack of support, comorbid conditions, family burdens.
The decision to stop medications is often thus a process: first jointly determine whether it is a good time, then plan the reduction, and finally monitor well‑being at subsequent stages.
Why the pace of reduction matters
Some people intuitively think of stopping medications in binary terms: “I take it / I don’t take it”. In practice a much safer approach is often gradual dose reduction, i.e. so‑called tapering.
Too rapid a change may be associated with two main problems:
withdrawal syndrome — sudden onset of physical and emotional symptoms after too-rapid dose reduction (dizziness, “brain zaps”, anxiety, sleep disturbances),
difficulty distinguishing whether current worsening stems from discontinuation or relapse of the disorder.
Gradual dose reduction allows closer observation of the body, responding to worrying signals and — if necessary — slowing the pace or returning to the previous level. It also creates space for parallel work on sleep, stress load, daily organisation and strategies for coping with tension.
When reduction may be risky
There are also situations where reduction — even if the patient strongly wishes to be medication-free — is considered higher risk. This includes, for example:
a recently experienced episode of severe depression or disorders with high suicide risk on the history,
many prior rapid relapses in a short time,
lack of life stability (e.g. divorce, company restructuring, recent bereavement, prolonged work overload),
cases where prior improvement was primarily due to medication alone, without parallel psychotherapy or lifestyle work.
In such cases the decision to stop medications may be postponed or linked with a longer preparatory period to avoid unnecessarily increasing relapse risk.
Viewing the decision to stop medications as part of a broader plan
From a holistic approach perspective, dose reduction is not a separate, isolated episode but part of a broader process. It is worth that it is accompanied by:
continuing or starting psychotherapy,
work on nervous system regulation (sleep, circadian rhythm, daytime arousal levels),
real changes in workload and responsibility (particularly for leaders and people at high risk of burnout),
careful monitoring of the first delicate signs of worsening rather than waiting until symptoms become severe.
Thanks to this, reducing psychiatric medications ceases to be only about “how many milligrams less” and becomes part of a comprehensive mental health strategy.
Summary
The question “when does medication reduction make sense” has no single universal answer. It depends on the diagnosis, number of prior episodes, treatment duration, current life situation and available supports. For some people safe gradual dose reduction after a stabilisation period is appropriate; for others continuation of treatment unchanged is safer.
In every case the decision to stop medications should be made individually with the treating doctor, considering benefits, risks and alternative scenarios. The information in this article is general and educational. It does not replace medical advice or individualized diagnostic or therapeutic recommendations. Changes in pharmacological treatment — including reducing or stopping antidepressants and other psychiatric medications — require a personal consultation with a doctor and assessment of the full clinical picture.
Selected references
National Institute for Health and Care Excellence (NICE). Depression in adults: treatment and management.
Royal College of Psychiatrists. Stopping antidepressants.
Geddes J.R., Miklowitz D.J. Treatment of bipolar disorder. Lancet.
Horowitz M.A., Taylor D. Tapering of SSRI treatment to mitigate withdrawal symptoms. Journal of Affective Disorders.
Canadian Network for Mood and Anxiety Treatments (CANMAT). Guidelines for the management of major depressive disorder.
